A. Blouin et al., A novel procedure for daily measurements of hemodynamical, hematological, and biochemical parameters in conscious unrestrained rats, J PHARM TOX, 44(3), 2000, pp. 489-505
Citations number
58
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Accurate and chronic measurements of various parameters in conscious animal
s are fundamental for depicting pathological chronic conditions and their e
tiology in many experimental models, but they are often difficult to achiev
e. The aim of the present work was to develop and describe step-by-step a r
eproducible surgical procedure and daily manipulations for continuous, chro
nic use of conscious rats as models towards a better understanding of vario
us cardiovascular and renal diseases and the testing of novel pharmacologic
al drugs. The complete apparatus involved the use of a series of specialize
d devices (harness, rotating swivel, revolving arm) supporting a flexible,
permanently implanted vascular catheter into the left femoral artery up to
the abdominal aorta connected to a miniaturized individual peristaltic pump
for delivering fluid at a constant rate. Such a set-up also enabled easy,
quick, and reproducible daily blood sampling for the evaluation of more tha
n 20 parameters, including the monitoring of heart rate (HR) and blood pres
sure in freely moving conscious rats. The overall success and survival rate
reached 98% over 14 days and could be extended further This model represen
ts a much needed and valuable advance in surgical research techniques to ev
aluate the hemodynamic, hematological, biochemical, pharmacokinetic, and to
xicological profile of any new drugs over time in conscious animal models s
uch as rats. What makes this procedure satisfactory is the long-term reliab
le arterial access and reproducibility of the methodological approach for a
ccurate and continuous measurements, minimizing the stress or invasiveness
associated with the use of currently employed systems. (C) 2001 Elsevier Sc
ience Inc. All rights reserved.